Crinecerfont is an investigational drug being studied for the treatment of conditions related to excess adrenal corticosteroid production, such as Cushing's disease. It is a selective CRF1 receptor antagonist, which helps to reduce the excessive release of cortisol, a hormone involved in stress and metabolism. By blocking the CRF1 receptor, Crinecerfont may help control symptoms like weight gain, high blood pressure, and fatigue associated with Cushing? disease. It is still under clinical investigation for its safety and efficacy.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Crinecerfont and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Crinecerfont impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Crinecerfont-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
